跳至主要内容
临床试验/NCT04575233
NCT04575233已完成不适用

Laparoscopic- Vs Ultrasound-guided Transversus Abdominis Plane Block in Laparoscopic Colectomy: a Prospective Randomized Controlled Trial

Davide La Regina2 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2018年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
116
试验地点
2
主要终点
Opioids consumption

研究概览

简要总结

The purpose of this study is to compare the postoperative pain, the time needed and other clinical outcomes in patients who, during laparoscopic colectomy, will be injected with a local anesthetic (Ropivacaine) through an ultrasound guided technique performed by the anaesthesiologist or throught a laparoscopic assisted technique performed by the surgeon

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients candidates to laparoscopic colorectal surgery
  • Signed informed consent

排除标准

  • Age < 18 years old
  • Pregnancy
  • Allergy to local anaesthetics
  • Spinal or epidural analgesia
  • Acute inflammatory abdominal pathologies
  • Chronic pain syndrome
  • Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDS)

研究组 & 干预措施

Laparoscopic Transversus Abdominis Plane (L-TAP) group

Experimental

Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control

干预措施: laparoscopic-assisted Transversus Abdominis Plane (TAP) block (Procedure)

Laparoscopic Transversus Abdominis Plane (L-TAP) group

Experimental

Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control

干预措施: Ropivacaine (Drug)

Ultrasound Transversus Abdominis Plane (U-TAP) group

Active Comparator

Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control

干预措施: ultrasound-assisted Transversus Abdominis Plane (TAP) block (Procedure)

Ultrasound Transversus Abdominis Plane (U-TAP) group

Active Comparator

Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control

干预措施: Ropivacaine (Drug)

结局指标

主要结局

Opioids consumption

时间窗: 24 hours from surgery

Opioid consumption measured in morphine milligram equivalents (MME) per day

次要结局

  • Time required to perform the (Transversus Abdominis Plane) TAP block(during procedure)
  • Opioid consumption within the first 48 hours after the operation(48 hours from surgery)
  • postoperative pain(at 3, 6, 12, 24 hours from surgery)
  • length of hospital stay(during hospitalization,approximately 6 days)

研究者

发起方
Davide La Regina
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Davide La Regina

Principal Investigator

Ente Ospedaliero Cantonale, Bellinzona

研究点 (2)

Loading locations...

相似试验